Literature DB >> 12803467

Evolution and diversity of HIV-1 in Africa--a review.

Maria A Papathanasopoulos1, Gillian M Hunt, Caroline T Tiemessen.   

Abstract

The HIV/AIDS pandemic represents a major development crisis for the African continent, which is the worst affected region in the world. Currently, almost 30 of the 42 million people infected with HIV worldwide live in Africa. AIDS in humans is caused by two lentiviruses, HIV-1 and HIV-2, which entered the human population by zoonotic transmissions from at least two different African primate species. Extensive phylogenetic analyses of partial and full-length genome sequences have helped to gain insights into the evolutionary biology and population dynamics of HIV. One of the major characteristics of HIV is its rapid evolution, which has resulted in substantial genetic diversity amongst different isolates, the majority of which are represented in Africa. Genetic variability of HIV and any consequent phenotypic variation poses a significant challenge to disease control and surveillance in different geographic regions of Africa. This review focuses on the origins and evolution of HIV, current classification and diversity of HIV isolates in Africa and provides an extensive account of the geographic distribution of HIV types, groups, and subtypes in each of the 49 African countries. Numerous epidemiological studies have provided a picture of HIV distribution patterns in most countries in Africa, and these show increasing evidence of the importance of HIV-1 recombinants. In particular, this review highlights that our current understanding of HIV distribution in Africa is incomplete and inadequately represents the diversity of the virus, and underscores the need for ongoing surveillance.

Entities:  

Mesh:

Year:  2003        PMID: 12803467     DOI: 10.1023/a:1023435429841

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  171 in total

1.  World Bank allocates funds to help war-torn Sierra Leone fight HIV/AIDS.

Authors:  Clar Ni Chonghaile
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

2.  HIV-1 Subtype A, D, G, AG and unclassified sequences identified in South Africa.

Authors:  Helba Bredell; Gillian Hunt; Alison Casteling; Tonie Cilliers; Celia Rademeyer; Mia Coetzer; Steven Miller; David Johnson; Caroline T Tiemessen; Desmond J Martin; Carolyn Williamson; Lynn Morris
Journal:  AIDS Res Hum Retroviruses       Date:  2002-06-10       Impact factor: 2.205

3.  env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area.

Authors:  S Corbet; M C Müller-Trutwin; P Versmisse; S Delarue; A Ayouba; J Lewis; S Brunak; P Martin; F Brun-Vezinet; F Simon; F Barre-Sinoussi; P Mauclere
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  HIV infection and HIV-1 clades among pregnant women in Harare, Zimbabwe.

Authors:  C L Obi; H P McAdoo; M Murray; S A Tswana; S R Moyo
Journal:  Cent Afr J Med       Date:  1997-07

5.  Origin of HIV type 1 in colonial French Equatorial Africa?

Authors:  A Chitnis; D Rawls; J Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2000-01-01       Impact factor: 2.205

6.  Presence of diverse human immunodeficiency virus type 1 viral variants in Cameroon.

Authors:  P N Fonjungo; E N Mpoudi; J N Torimiro; G A Alemnji; L T Eno; J N Nkengasong; F Gao; M Rayfield; T M Folks; D Pieniazek; R B Lal
Journal:  AIDS Res Hum Retroviruses       Date:  2000-09-01       Impact factor: 2.205

7.  Human immunodeficiency virus (HIV) subtype surveillance of African-born persons at risk for group O and group N HIV infections in the United States.

Authors:  P S Sullivan; A N Do; D Ellenberger; C P Pau; S Paul; K Robbins; M Kalish; C Storck; C A Schable; H Wise; C Tetteh; J L Jones; J McFarland; C Yang; R B Lal; J W Ward
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

8.  Isolation of a simian immunodeficiency virus related to human immunodeficiency virus type 2 from a west African pet sooty mangabey.

Authors:  P A Marx; Y Li; N W Lerche; S Sutjipto; A Gettie; J A Yee; B H Brotman; A M Prince; A Hanson; R G Webster
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

9.  Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants.

Authors:  J K Carr; M O Salminen; J Albert; E Sanders-Buell; D Gotte; D L Birx; F E McCutchan
Journal:  Virology       Date:  1998-07-20       Impact factor: 3.616

10.  Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the central African Republic.

Authors:  E Murphy; B Korber; M C Georges-Courbot; B You; A Pinter; D Cook; M P Kieny; A Georges; C Mathiot; F Barré-Sinoussi
Journal:  AIDS Res Hum Retroviruses       Date:  1993-10       Impact factor: 2.205

View more
  16 in total

1.  Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals.

Authors:  Georgios Pollakis; Almaz Abebe; Aletta Kliphuis; Moustapha I M Chalaby; Margreet Bakker; Yohannes Mengistu; Margreet Brouwer; Jaap Goudsmit; Hanneke Schuitemaker; William A Paxton
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

2.  Characterization of primary isolates of HIV type 1 CRF28_BF, CRF29_BF, and unique BF recombinants circulating in São Paulo, Brazil.

Authors:  Fernando Lucas Melo; Leda Fátima Jamal; Paolo Marinho de Andrade Zanotto
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-16       Impact factor: 2.205

3.  Destruction of microbial collections in response to select agent and toxin list regulations.

Authors:  Arturo Casadevall; Michael J Imperiale
Journal:  Biosecur Bioterror       Date:  2010-06

Review 4.  Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience.

Authors:  Flavia Ferrantelli; Stefano Buttò; Aurelio Cafaro; Britta Wahren; Barbara Ensoli
Journal:  Springer Semin Immunopathol       Date:  2006-09-16

5.  Performance of the new Roche Cobas AmpliPrep-Cobas TaqMan version 2.0 human immunodeficiency virus type 1 assay.

Authors:  Lesley Scott; Sergio Carmona; Wendy Stevens
Journal:  J Clin Microbiol       Date:  2009-08-05       Impact factor: 5.948

6.  Use of a prequalification panel for rapid scale-up of high-throughput HIV viral load testing.

Authors:  Lesley E Scott; Sergio Carmona; Natasha Gous; Pamela Horsfield; Melanie Mackay; Wendy Stevens
Journal:  J Clin Microbiol       Date:  2012-09-19       Impact factor: 5.948

7.  Clinical and immunological status of a newly diagnosed HIV positive population, in Marrakech, Morocco.

Authors:  B Admou; E Elharti; H Oumzil; A Addebbous; M Amine; K Zahlane; N Soraa; L Zougaghi; K Haouach; N Tassi; L Aajly; L Chabaa; R El Aouad
Journal:  Afr Health Sci       Date:  2010-12       Impact factor: 0.927

8.  Divergence and recombination of clinical herpes simplex virus type 2 isolates.

Authors:  Peter Norberg; Mabula J Kasubi; Lars Haarr; Tomas Bergström; Jan-Ake Liljeqvist
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

9.  An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1.

Authors:  Sergei L Kosakovsky Pond; David Posada; Eric Stawiski; Colombe Chappey; Art F Y Poon; Gareth Hughes; Esther Fearnhill; Mike B Gravenor; Andrew J Leigh Brown; Simon D W Frost
Journal:  PLoS Comput Biol       Date:  2009-11-26       Impact factor: 4.475

10.  Phylodynamics of HIV-1 from a phase-III AIDS vaccine trial in North America.

Authors:  Marcos Pérez-Losada; David V Jobes; Faruk Sinangil; Keith A Crandall; David Posada; Phillip W Berman
Journal:  Mol Biol Evol       Date:  2009-10-28       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.